Zdrowie i gospodarka · 10/05/2022

FDA Releases Draft Guidance on Benefit-Risk Considerations for Product Quality Assessments

The US Food and Drug Administration (FDA) has published a draft guidance outlining its benefit-risk principles for evaluating product quality issues in new drug and biologics applications, as well as other regulatory submissions.